

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 9.60250199 |
| 2 | ensheathment of neurons (GO:0007272) | 7.38943400 |
| 3 | axon ensheathment (GO:0008366) | 7.38943400 |
| 4 | myelination (GO:0042552) | 7.37005159 |
| 5 | cholesterol biosynthetic process (GO:0006695) | 7.13106235 |
| 6 | sterol biosynthetic process (GO:0016126) | 6.20994014 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.13862488 |
| 8 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.63219772 |
| 9 | isoprenoid biosynthetic process (GO:0008299) | 5.61098600 |
| 10 | myelin maintenance (GO:0043217) | 5.30187118 |
| 11 | amyloid precursor protein metabolic process (GO:0042982) | 5.03499974 |
| 12 | regulation of collateral sprouting (GO:0048670) | 5.00546817 |
| 13 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.87364178 |
| 14 | negative regulation of neurotransmitter transport (GO:0051589) | 4.65563789 |
| 15 | glycerophospholipid catabolic process (GO:0046475) | 4.40420875 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 4.38723870 |
| 17 | virion attachment to host cell (GO:0019062) | 4.38723870 |
| 18 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.35819116 |
| 19 | substantia nigra development (GO:0021762) | 4.34638283 |
| 20 | response to methylmercury (GO:0051597) | 4.31196144 |
| 21 | oligodendrocyte differentiation (GO:0048709) | 4.27263291 |
| 22 | cullin deneddylation (GO:0010388) | 4.25188440 |
| 23 | response to lipoprotein particle (GO:0055094) | 4.22745923 |
| 24 | response to redox state (GO:0051775) | 4.22263624 |
| 25 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.20762023 |
| 26 | creatine metabolic process (GO:0006600) | 4.18067291 |
| 27 | positive regulation of actin filament depolymerization (GO:0030836) | 4.17733600 |
| 28 | photoreceptor cell differentiation (GO:0046530) | 4.15545929 |
| 29 | eye photoreceptor cell differentiation (GO:0001754) | 4.15545929 |
| 30 | astrocyte development (GO:0014002) | 4.13510610 |
| 31 | protein deneddylation (GO:0000338) | 4.04751627 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 4.02230133 |
| 33 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.98811376 |
| 34 | amyloid precursor protein catabolic process (GO:0042987) | 3.90046562 |
| 35 | nucleotide transmembrane transport (GO:1901679) | 3.85025823 |
| 36 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.84032684 |
| 37 | DNA deamination (GO:0045006) | 3.83619909 |
| 38 | very long-chain fatty acid metabolic process (GO:0000038) | 3.75020785 |
| 39 | protein neddylation (GO:0045116) | 3.74954071 |
| 40 | platelet dense granule organization (GO:0060155) | 3.73139532 |
| 41 | L-amino acid import (GO:0043092) | 3.66281353 |
| 42 | asymmetric protein localization (GO:0008105) | 3.64807475 |
| 43 | negative regulation of protein localization to cell surface (GO:2000009) | 3.64013141 |
| 44 | apical protein localization (GO:0045176) | 3.62174864 |
| 45 | import into cell (GO:0098657) | 3.61020459 |
| 46 | myelination in peripheral nervous system (GO:0022011) | 3.60430215 |
| 47 | peripheral nervous system axon ensheathment (GO:0032292) | 3.60430215 |
| 48 | GPI anchor biosynthetic process (GO:0006506) | 3.59944152 |
| 49 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.59211373 |
| 50 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.54257659 |
| 51 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.48227325 |
| 52 | glycosylceramide metabolic process (GO:0006677) | 3.47800438 |
| 53 | magnesium ion transport (GO:0015693) | 3.45474439 |
| 54 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.41399081 |
| 55 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.41030972 |
| 56 | GPI anchor metabolic process (GO:0006505) | 3.38505729 |
| 57 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.37763092 |
| 58 | mannosylation (GO:0097502) | 3.35702010 |
| 59 | proteasome assembly (GO:0043248) | 3.34884016 |
| 60 | thioester biosynthetic process (GO:0035384) | 3.33188132 |
| 61 | acyl-CoA biosynthetic process (GO:0071616) | 3.33188132 |
| 62 | metallo-sulfur cluster assembly (GO:0031163) | 3.32534317 |
| 63 | iron-sulfur cluster assembly (GO:0016226) | 3.32534317 |
| 64 | L-serine metabolic process (GO:0006563) | 3.31954262 |
| 65 | positive regulation of mitochondrial fission (GO:0090141) | 3.29796618 |
| 66 | positive regulation of pseudopodium assembly (GO:0031274) | 3.27882278 |
| 67 | adhesion of symbiont to host (GO:0044406) | 3.27486985 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27038754 |
| 69 | anterograde synaptic vesicle transport (GO:0048490) | 3.22191626 |
| 70 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.18861392 |
| 71 | regulation of lipoprotein metabolic process (GO:0050746) | 3.17803490 |
| 72 | axon development (GO:0061564) | 3.17468314 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.17108124 |
| 74 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.16391095 |
| 75 | response to lead ion (GO:0010288) | 3.11445152 |
| 76 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.11141021 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09617839 |
| 78 | mitotic nuclear envelope reassembly (GO:0007084) | 3.09555926 |
| 79 | nuclear envelope reassembly (GO:0031468) | 3.09555926 |
| 80 | cytidine metabolic process (GO:0046087) | 3.08394588 |
| 81 | cytidine catabolic process (GO:0006216) | 3.08394588 |
| 82 | cytidine deamination (GO:0009972) | 3.08394588 |
| 83 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.07674792 |
| 84 | negative regulation of JUN kinase activity (GO:0043508) | 3.07238417 |
| 85 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.06919062 |
| 86 | signal peptide processing (GO:0006465) | 3.06294334 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.03571091 |
| 88 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.03571091 |
| 89 | limb bud formation (GO:0060174) | 3.03332437 |
| 90 | ear development (GO:0043583) | 3.02670163 |
| 91 | peripheral nervous system development (GO:0007422) | 3.01800290 |
| 92 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.01159293 |
| 93 | sequestering of actin monomers (GO:0042989) | 3.01001211 |
| 94 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99812277 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99812277 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99812277 |
| 97 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.99645167 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98208601 |
| 99 | alcohol biosynthetic process (GO:0046165) | 2.97763490 |
| 100 | glial cell development (GO:0021782) | 2.97406459 |
| 101 | protein-cofactor linkage (GO:0018065) | 2.95839034 |
| 102 | Rap protein signal transduction (GO:0032486) | 2.95634869 |
| 103 | response to hepatocyte growth factor (GO:0035728) | 2.94073456 |
| 104 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.94073456 |
| 105 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91314859 |
| 106 | L-methionine salvage (GO:0071267) | 2.87917567 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 2.87917567 |
| 108 | amino acid salvage (GO:0043102) | 2.87917567 |
| 109 | negative regulation of ligase activity (GO:0051352) | 2.87915946 |
| 110 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.87915946 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86420572 |
| 112 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.85781481 |
| 113 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.85157205 |
| 114 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84748260 |
| 115 | estrogen biosynthetic process (GO:0006703) | 2.84459045 |
| 116 | cholesterol metabolic process (GO:0008203) | 2.83678197 |
| 117 | heme transport (GO:0015886) | 2.82512394 |
| 118 | L-phenylalanine catabolic process (GO:0006559) | 2.82330882 |
| 119 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.82330882 |
| 120 | regulation of chronic inflammatory response (GO:0002676) | 2.81047071 |
| 121 | regulation of pseudopodium assembly (GO:0031272) | 2.80187932 |
| 122 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.78905810 |
| 123 | neural nucleus development (GO:0048857) | 2.78864968 |
| 124 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.78660395 |
| 125 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.78223073 |
| 126 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.78223073 |
| 127 | positive regulation of interleukin-17 production (GO:0032740) | 2.77771358 |
| 128 | negative regulation of axonogenesis (GO:0050771) | 2.77381022 |
| 129 | chaperone-mediated protein transport (GO:0072321) | 2.76184984 |
| 130 | membrane tubulation (GO:0097320) | 2.76176946 |
| 131 | membrane raft organization (GO:0031579) | 2.76059722 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.75435954 |
| 133 | purine-containing compound salvage (GO:0043101) | 2.75232612 |
| 134 | negative regulation of interleukin-17 production (GO:0032700) | 2.74120277 |
| 135 | leukocyte aggregation (GO:0070486) | 2.71903949 |
| 136 | steroid biosynthetic process (GO:0006694) | 2.71629401 |
| 137 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69835451 |
| 138 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69351098 |
| 139 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.69215438 |
| 140 | activated T cell proliferation (GO:0050798) | 2.68531495 |
| 141 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.67427137 |
| 142 | neutrophil activation involved in immune response (GO:0002283) | 2.67350904 |
| 143 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67305045 |
| 144 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.67132786 |
| 145 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.66347503 |
| 146 | nucleotide transport (GO:0006862) | 2.66010216 |
| 147 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61295389 |
| 148 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61295389 |
| 149 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.60691105 |
| 150 | T cell migration (GO:0072678) | 2.59046266 |
| 151 | neutrophil activation (GO:0042119) | 2.57744930 |
| 152 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.57019784 |
| 153 | actin nucleation (GO:0045010) | 2.56880141 |
| 154 | purine nucleotide salvage (GO:0032261) | 2.56377130 |
| 155 | positive regulation of ligase activity (GO:0051351) | 2.55814742 |
| 156 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.53696408 |
| 157 | piRNA metabolic process (GO:0034587) | 2.53551167 |
| 158 | granulocyte activation (GO:0036230) | 2.53450635 |
| 159 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.50559788 |
| 160 | eosinophil chemotaxis (GO:0048245) | 2.48771059 |
| 161 | regulation of cellular amine metabolic process (GO:0033238) | 2.48746690 |
| 162 | anterograde axon cargo transport (GO:0008089) | 2.43593956 |
| 163 | negative regulation of membrane potential (GO:0045837) | 2.43429442 |
| 164 | DNA double-strand break processing (GO:0000729) | 2.42809657 |
| 165 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.40624438 |
| 166 | immunoglobulin mediated immune response (GO:0016064) | 2.39312575 |
| 167 | viral protein processing (GO:0019082) | 2.39050081 |
| 168 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.38468764 |
| 169 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.38063273 |
| 170 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.36015396 |
| 171 | negative regulation of T cell apoptotic process (GO:0070233) | 2.35425919 |
| 172 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.34980598 |
| 173 | negative regulation of protein ubiquitination (GO:0031397) | 2.34893939 |
| 174 | intracellular protein transmembrane import (GO:0044743) | 2.34727376 |
| 175 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.32780872 |
| 176 | negative regulation by host of viral transcription (GO:0043922) | 2.31927418 |
| 177 | de novo posttranslational protein folding (GO:0051084) | 2.31399628 |
| 178 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.29551990 |
| 179 | neurotransmitter uptake (GO:0001504) | 2.29458702 |
| 180 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.29293504 |
| 181 | nucleoside salvage (GO:0043174) | 2.29030555 |
| 182 | phagosome maturation (GO:0090382) | 2.28769792 |
| 183 | de novo protein folding (GO:0006458) | 2.27738389 |
| 184 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.27375150 |
| 185 | positive regulation of lamellipodium assembly (GO:0010592) | 2.26732379 |
| 186 | regulation of T cell tolerance induction (GO:0002664) | 2.25422361 |
| 187 | positive regulation of TOR signaling (GO:0032008) | 2.24896898 |
| 188 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.23285965 |
| 189 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.23285965 |
| 190 | eosinophil migration (GO:0072677) | 2.23262234 |
| 191 | regulation of ligase activity (GO:0051340) | 2.22588240 |
| 192 | protein refolding (GO:0042026) | 2.22556079 |
| 193 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.22176966 |
| 194 | axon ensheathment in central nervous system (GO:0032291) | 11.9517188 |
| 195 | central nervous system myelination (GO:0022010) | 11.9517188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.00872501 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.17342984 |
| 3 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 3.72493873 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.79390199 |
| 5 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.68488717 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.63093257 |
| 7 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.62648323 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.59419900 |
| 9 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.58852815 |
| 10 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.58823196 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57996328 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.57970188 |
| 13 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.57334948 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.56065702 |
| 15 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.40362586 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.29088687 |
| 17 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.22563275 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.17337015 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16892426 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15874752 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.98426309 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.97903227 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.94840059 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.88823937 |
| 25 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.81033848 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77638794 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77407736 |
| 28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.74322486 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.74322486 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72954067 |
| 31 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.72642004 |
| 32 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.63887238 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60942867 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60926552 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60701017 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60270879 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59673207 |
| 38 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.52747598 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52134149 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51117755 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50817840 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50768027 |
| 43 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48995993 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47003847 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46786742 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.46239189 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46149147 |
| 48 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.45875054 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45698448 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45286469 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42843542 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.42764205 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41225745 |
| 54 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40749279 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40603578 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39454013 |
| 57 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38090262 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.38076531 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37463592 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36603231 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35491019 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33505377 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32322063 |
| 64 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29948813 |
| 65 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28526706 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.26662581 |
| 67 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26546504 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25615475 |
| 69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25044631 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.25014547 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24777103 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23299064 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22893801 |
| 74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22839444 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22289761 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21167112 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19569998 |
| 78 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.19386946 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19337732 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18923477 |
| 81 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18524444 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16585531 |
| 83 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.16553630 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16499428 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15849930 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15634728 |
| 87 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13268702 |
| 88 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13268702 |
| 89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.13003323 |
| 90 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11880282 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11144241 |
| 92 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10986454 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.10215409 |
| 94 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09606998 |
| 95 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09564501 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09224019 |
| 97 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07426428 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06904179 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06153928 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05444436 |
| 101 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04650475 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04519497 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03369792 |
| 104 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.02516047 |
| 105 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02374970 |
| 106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98289830 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97372145 |
| 108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97218888 |
| 109 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95901242 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95894533 |
| 111 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.94935699 |
| 112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94658062 |
| 113 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94523915 |
| 114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94456064 |
| 115 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94076581 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93615088 |
| 117 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.93241975 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93094603 |
| 119 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92268925 |
| 120 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92190872 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92075446 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91470115 |
| 123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91058176 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90265473 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90095234 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.89419330 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89379182 |
| 128 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89096489 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88703648 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88037458 |
| 131 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87825287 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87369852 |
| 133 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86995893 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86774539 |
| 135 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85726672 |
| 136 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84963150 |
| 137 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84676099 |
| 138 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84311799 |
| 139 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84202485 |
| 140 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.83795696 |
| 141 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.83450141 |
| 142 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.83137739 |
| 143 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82596084 |
| 144 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.82439727 |
| 145 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82142919 |
| 146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81995633 |
| 147 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.80379159 |
| 148 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80281343 |
| 149 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.79838007 |
| 150 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79576594 |
| 151 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.79120178 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78919360 |
| 153 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.78485207 |
| 154 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78355522 |
| 155 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78329969 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78017225 |
| 157 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.75825148 |
| 158 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75698530 |
| 159 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.75650459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 6.72718643 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.38185476 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.91593993 |
| 4 | MP0003690_abnormal_glial_cell | 3.80986042 |
| 5 | MP0003724_increased_susceptibility_to | 3.44540631 |
| 6 | MP0005671_abnormal_response_to | 3.20189837 |
| 7 | MP0005171_absent_coat_pigmentation | 3.03571802 |
| 8 | MP0002102_abnormal_ear_morphology | 2.77946935 |
| 9 | MP0004134_abnormal_chest_morphology | 2.70377985 |
| 10 | MP0009785_altered_susceptibility_to | 2.66558893 |
| 11 | MP0001529_abnormal_vocalization | 2.56024165 |
| 12 | MP0003634_abnormal_glial_cell | 2.48874665 |
| 13 | MP0003136_yellow_coat_color | 2.48770508 |
| 14 | MP0005451_abnormal_body_composition | 2.48569759 |
| 15 | MP0003329_amyloid_beta_deposits | 2.47192589 |
| 16 | MP0001905_abnormal_dopamine_level | 2.44438498 |
| 17 | MP0008260_abnormal_autophagy | 2.42230614 |
| 18 | MP0004742_abnormal_vestibular_system | 2.38896632 |
| 19 | MP0004885_abnormal_endolymph | 2.38693209 |
| 20 | MP0005409_darkened_coat_color | 2.20777343 |
| 21 | MP0003632_abnormal_nervous_system | 2.16834056 |
| 22 | MP0001485_abnormal_pinna_reflex | 2.14779949 |
| 23 | MP0000566_synostosis | 2.10176589 |
| 24 | MP0008058_abnormal_DNA_repair | 2.03837147 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.99341670 |
| 26 | MP0000383_abnormal_hair_follicle | 1.92497941 |
| 27 | MP0005408_hypopigmentation | 1.90555046 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.90150230 |
| 29 | MP0003880_abnormal_central_pattern | 1.88434976 |
| 30 | MP0008057_abnormal_DNA_replication | 1.87160918 |
| 31 | MP0010678_abnormal_skin_adnexa | 1.86031928 |
| 32 | MP0003195_calcinosis | 1.83847661 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.79272020 |
| 34 | MP0004142_abnormal_muscle_tone | 1.78913620 |
| 35 | MP0004270_analgesia | 1.78495678 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.77274716 |
| 37 | MP0009764_decreased_sensitivity_to | 1.77097959 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.76198407 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.73452395 |
| 40 | MP0000462_abnormal_digestive_system | 1.69281880 |
| 41 | MP0006054_spinal_hemorrhage | 1.67475485 |
| 42 | MP0001800_abnormal_humoral_immune | 1.66292738 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.65950150 |
| 44 | MP0000778_abnormal_nervous_system | 1.65925149 |
| 45 | MP0008004_abnormal_stomach_pH | 1.65444440 |
| 46 | MP0002736_abnormal_nociception_after | 1.65254044 |
| 47 | MP0004381_abnormal_hair_follicle | 1.64417114 |
| 48 | MP0002723_abnormal_immune_serum | 1.61825925 |
| 49 | MP0000604_amyloidosis | 1.58880665 |
| 50 | MP0004147_increased_porphyrin_level | 1.57276719 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.56490072 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.56064297 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.56017937 |
| 54 | MP0002229_neurodegeneration | 1.54891003 |
| 55 | MP0001984_abnormal_olfaction | 1.52849236 |
| 56 | MP0003436_decreased_susceptibility_to | 1.52731497 |
| 57 | MP0001819_abnormal_immune_cell | 1.50659068 |
| 58 | MP0004859_abnormal_synaptic_plasticity | 1.50483035 |
| 59 | MP0006072_abnormal_retinal_apoptosis | 1.48655526 |
| 60 | MP0009745_abnormal_behavioral_response | 1.46941686 |
| 61 | MP0003011_delayed_dark_adaptation | 1.45179564 |
| 62 | MP0006082_CNS_inflammation | 1.44296467 |
| 63 | MP0005025_abnormal_response_to | 1.40127070 |
| 64 | MP0002272_abnormal_nervous_system | 1.38926147 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.36429774 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.35032624 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.31412860 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.30537260 |
| 69 | MP0001661_extended_life_span | 1.30086955 |
| 70 | MP0001299_abnormal_eye_distance/ | 1.29113615 |
| 71 | MP0005410_abnormal_fertilization | 1.28817908 |
| 72 | MP0000647_abnormal_sebaceous_gland | 1.27384055 |
| 73 | MP0003937_abnormal_limbs/digits/tail_de | 1.26693738 |
| 74 | MP0001853_heart_inflammation | 1.25462472 |
| 75 | MP0000343_altered_response_to | 1.24277876 |
| 76 | MP0002938_white_spotting | 1.24185829 |
| 77 | MP0003631_nervous_system_phenotype | 1.24057599 |
| 78 | MP0009697_abnormal_copulation | 1.23360645 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.21572065 |
| 80 | MP0003075_altered_response_to | 1.21529169 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19919614 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 1.17915476 |
| 83 | MP0002398_abnormal_bone_marrow | 1.15574450 |
| 84 | MP0001851_eye_inflammation | 1.15325321 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.14883366 |
| 86 | MP0006276_abnormal_autonomic_nervous | 1.14353700 |
| 87 | MP0001486_abnormal_startle_reflex | 1.14273300 |
| 88 | MP0002132_abnormal_respiratory_system | 1.13248801 |
| 89 | MP0003186_abnormal_redox_activity | 1.12682759 |
| 90 | MP0000716_abnormal_immune_system | 1.10390779 |
| 91 | MP0005387_immune_system_phenotype | 1.09217075 |
| 92 | MP0001790_abnormal_immune_system | 1.09217075 |
| 93 | MP0001177_atelectasis | 1.08914502 |
| 94 | MP0008932_abnormal_embryonic_tissue | 1.08698009 |
| 95 | MP0003448_altered_tumor_morphology | 1.07813748 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 1.06836435 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.06818222 |
| 98 | MP0000689_abnormal_spleen_morphology | 1.05452900 |
| 99 | MP0002933_joint_inflammation | 1.05011694 |
| 100 | MP0003938_abnormal_ear_development | 1.04364698 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 1.03291140 |
| 102 | MP0000372_irregular_coat_pigmentation | 1.01967276 |
| 103 | MP0001845_abnormal_inflammatory_respons | 1.01582272 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.99985738 |
| 105 | MP0009763_increased_sensitivity_to | 0.99698076 |
| 106 | MP0002405_respiratory_system_inflammati | 0.99553892 |
| 107 | MP0009840_abnormal_foam_cell | 0.99374199 |
| 108 | MP0002722_abnormal_immune_system | 0.98891900 |
| 109 | MP0000955_abnormal_spinal_cord | 0.98560993 |
| 110 | MP0001542_abnormal_bone_strength | 0.97897314 |
| 111 | MP0003763_abnormal_thymus_physiology | 0.97828236 |
| 112 | MP0008873_increased_physiological_sensi | 0.97431129 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.96257937 |
| 114 | MP0003303_peritoneal_inflammation | 0.94883017 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.94173100 |
| 116 | MP0001764_abnormal_homeostasis | 0.93960590 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.93471888 |
| 118 | MP0003635_abnormal_synaptic_transmissio | 0.93094464 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.92730061 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.91106356 |
| 121 | MP0005195_abnormal_posterior_eye | 0.88787392 |
| 122 | MP0002063_abnormal_learning/memory/cond | 0.85757322 |
| 123 | MP0002064_seizures | 0.85179523 |
| 124 | MP0002653_abnormal_ependyma_morphology | 0.85140326 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.84700453 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.84470712 |
| 127 | MP0009046_muscle_twitch | 0.84125155 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.82585331 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 0.82018481 |
| 130 | MP0008469_abnormal_protein_level | 0.81669685 |
| 131 | MP0002067_abnormal_sensory_capabilities | 0.81403013 |
| 132 | MP0002572_abnormal_emotion/affect_behav | 0.81000340 |
| 133 | MP0004272_abnormal_basement_membrane | 0.80671882 |
| 134 | MP0004510_myositis | 0.80583724 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.80577394 |
| 136 | MP0000015_abnormal_ear_pigmentation | 0.79643371 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.79039912 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.78681523 |
| 139 | MP0003191_abnormal_cellular_cholesterol | 0.77067143 |
| 140 | MP0000747_muscle_weakness | 0.76806006 |
| 141 | MP0002429_abnormal_blood_cell | 0.76261788 |
| 142 | MP0002133_abnormal_respiratory_system | 0.73557035 |
| 143 | MP0005388_respiratory_system_phenotype | 0.73557035 |
| 144 | MP0003633_abnormal_nervous_system | 0.73148131 |
| 145 | MP0002090_abnormal_vision | 0.72341165 |
| 146 | MP0009765_abnormal_xenobiotic_induced | 0.71101128 |
| 147 | MP0002066_abnormal_motor_capabilities/c | 0.68629960 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.63216984 |
| 149 | MP0003718_maternal_effect | 0.62471151 |
| 150 | MP0001243_abnormal_dermal_layer | 0.62196278 |
| 151 | MP0002163_abnormal_gland_morphology | 0.61972202 |
| 152 | MP0004043_abnormal_pH_regulation | 0.60158087 |
| 153 | MP0004133_heterotaxia | 0.59384376 |
| 154 | MP0001348_abnormal_lacrimal_gland | 0.59186562 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.57823020 |
| 156 | MP0002148_abnormal_hypersensitivity_rea | 0.55480063 |
| 157 | MP0001340_abnormal_eyelid_morphology | 0.55130027 |
| 158 | MP0002419_abnormal_innate_immunity | 0.55119777 |
| 159 | MP0000377_abnormal_hair_follicle | 0.54496565 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53654188 |
| 161 | MP0000537_abnormal_urethra_morphology | 0.51761217 |
| 162 | MP0005253_abnormal_eye_physiology | 0.51417798 |
| 163 | MP0001293_anophthalmia | 0.50399651 |
| 164 | MP0000026_abnormal_inner_ear | 0.50267502 |
| 165 | MP0005000_abnormal_immune_tolerance | 0.49769165 |
| 166 | MP0003385_abnormal_body_wall | 0.49621968 |
| 167 | MP0005503_abnormal_tendon_morphology | 0.49573526 |
| 168 | MP0002098_abnormal_vibrissa_morphology | 0.47970109 |
| 169 | MP0009333_abnormal_splenocyte_physiolog | 0.47768016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.47907789 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.47907789 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.44936401 |
| 4 | Parakeratosis (HP:0001036) | 5.03013191 |
| 5 | Cerebral hypomyelination (HP:0006808) | 4.91347908 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 4.43131952 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 4.41718321 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.24127696 |
| 9 | Stomatitis (HP:0010280) | 4.15037916 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.07531497 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.07531497 |
| 12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.99772981 |
| 13 | Amyotrophic lateral sclerosis (HP:0007354) | 3.51413109 |
| 14 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.42157797 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.41848869 |
| 16 | Abnormal auditory evoked potentials (HP:0006958) | 3.33550231 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.30289279 |
| 18 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.28116986 |
| 19 | Increased IgM level (HP:0003496) | 3.24494599 |
| 20 | Onion bulb formation (HP:0003383) | 3.19708898 |
| 21 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.17922625 |
| 22 | Spastic paraparesis (HP:0002313) | 3.11875472 |
| 23 | Hepatosplenomegaly (HP:0001433) | 3.07584885 |
| 24 | Retinal dysplasia (HP:0007973) | 3.06692731 |
| 25 | Autoamputation (HP:0001218) | 3.05106150 |
| 26 | Insidious onset (HP:0003587) | 3.02787058 |
| 27 | Termporal pattern (HP:0011008) | 3.02787058 |
| 28 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.01754677 |
| 29 | Premature skin wrinkling (HP:0100678) | 3.01712276 |
| 30 | Leukodystrophy (HP:0002415) | 2.98388144 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.91749410 |
| 32 | Hypoplastic pelvis (HP:0008839) | 2.91130924 |
| 33 | Stridor (HP:0010307) | 2.90919563 |
| 34 | Spastic gait (HP:0002064) | 2.90565357 |
| 35 | Aplastic anemia (HP:0001915) | 2.83816280 |
| 36 | Alacrima (HP:0000522) | 2.81561539 |
| 37 | Mutism (HP:0002300) | 2.78011732 |
| 38 | Abnormality of the anterior horn cell (HP:0006802) | 2.77260592 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.77260592 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.76501129 |
| 41 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.76339061 |
| 42 | Intention tremor (HP:0002080) | 2.75794117 |
| 43 | Adrenal hypoplasia (HP:0000835) | 2.74467097 |
| 44 | Patchy hypopigmentation of hair (HP:0011365) | 2.73537386 |
| 45 | Absent septum pellucidum (HP:0001331) | 2.69328670 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.68991584 |
| 47 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.68991584 |
| 48 | Pheochromocytoma (HP:0002666) | 2.67494872 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 2.66385961 |
| 50 | T lymphocytopenia (HP:0005403) | 2.65861405 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65642218 |
| 52 | Mitochondrial inheritance (HP:0001427) | 2.65556284 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.64171001 |
| 54 | CNS hypomyelination (HP:0003429) | 2.63114444 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.61218175 |
| 56 | Prolonged neonatal jaundice (HP:0006579) | 2.60759708 |
| 57 | Anteriorly placed anus (HP:0001545) | 2.60099811 |
| 58 | Irregular epiphyses (HP:0010582) | 2.60097783 |
| 59 | Supranuclear gaze palsy (HP:0000605) | 2.55514732 |
| 60 | Hypoproteinemia (HP:0003075) | 2.51624598 |
| 61 | Clumsiness (HP:0002312) | 2.48765123 |
| 62 | Small epiphyses (HP:0010585) | 2.48694124 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.48098750 |
| 64 | White forelock (HP:0002211) | 2.48087616 |
| 65 | Epiphyseal dysplasia (HP:0002656) | 2.44719746 |
| 66 | Polyphagia (HP:0002591) | 2.42907732 |
| 67 | IgG deficiency (HP:0004315) | 2.40874755 |
| 68 | Gait imbalance (HP:0002141) | 2.39803046 |
| 69 | Congenital primary aphakia (HP:0007707) | 2.39639138 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.37213371 |
| 71 | Morphological abnormality of the inner ear (HP:0011390) | 2.37003617 |
| 72 | Postnatal microcephaly (HP:0005484) | 2.35729078 |
| 73 | Coronal craniosynostosis (HP:0004440) | 2.34602177 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33818012 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33449412 |
| 76 | Akinesia (HP:0002304) | 2.32208845 |
| 77 | Hepatocellular necrosis (HP:0001404) | 2.31519978 |
| 78 | Abnormality of the septum pellucidum (HP:0007375) | 2.30367195 |
| 79 | Increased CSF lactate (HP:0002490) | 2.30134213 |
| 80 | Increased hepatocellular lipid droplets (HP:0006565) | 2.29070404 |
| 81 | Volvulus (HP:0002580) | 2.28445637 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 2.28178366 |
| 83 | Nephrogenic diabetes insipidus (HP:0009806) | 2.25593944 |
| 84 | Acute encephalopathy (HP:0006846) | 2.25172599 |
| 85 | Anomalous pulmonary venous return (HP:0010772) | 2.24216217 |
| 86 | Progressive inability to walk (HP:0002505) | 2.23135915 |
| 87 | Scanning speech (HP:0002168) | 2.22179956 |
| 88 | Brushfield spots (HP:0001088) | 2.21582278 |
| 89 | Decreased lacrimation (HP:0000633) | 2.21008128 |
| 90 | Abnormality of macular pigmentation (HP:0008002) | 2.20421541 |
| 91 | Erythroderma (HP:0001019) | 2.18582778 |
| 92 | Type II lissencephaly (HP:0007260) | 2.18193462 |
| 93 | Stenosis of the external auditory canal (HP:0000402) | 2.17545783 |
| 94 | Methylmalonic aciduria (HP:0012120) | 2.16366885 |
| 95 | Split foot (HP:0001839) | 2.15716019 |
| 96 | Esophageal atresia (HP:0002032) | 2.14827485 |
| 97 | Hepatic necrosis (HP:0002605) | 2.14754369 |
| 98 | Hemiplegia (HP:0002301) | 2.12740014 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 2.11336107 |
| 100 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11306589 |
| 101 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.10570215 |
| 102 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.10570215 |
| 103 | Single umbilical artery (HP:0001195) | 2.10570215 |
| 104 | Methylmalonic acidemia (HP:0002912) | 2.10565806 |
| 105 | Delayed epiphyseal ossification (HP:0002663) | 2.10186976 |
| 106 | Thickened helices (HP:0000391) | 2.10005905 |
| 107 | Paraparesis (HP:0002385) | 2.09381880 |
| 108 | Abnormality of macrophages (HP:0004311) | 2.09061439 |
| 109 | Cupped ear (HP:0000378) | 2.08980976 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08741839 |
| 111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08653176 |
| 112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04183402 |
| 113 | Dysmetria (HP:0001310) | 2.04077309 |
| 114 | Relative macrocephaly (HP:0004482) | 2.03461399 |
| 115 | Constricted visual fields (HP:0001133) | 2.02271125 |
| 116 | Increased circulating renin level (HP:0000848) | 2.01006378 |
| 117 | Lactic acidosis (HP:0003128) | 2.00149333 |
| 118 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00080392 |
| 119 | Abnormality of the pulmonary veins (HP:0011718) | 2.00034464 |
| 120 | Cerebral edema (HP:0002181) | 1.99936369 |
| 121 | Barrel-shaped chest (HP:0001552) | 1.99842755 |
| 122 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98548277 |
| 123 | Abnormal protein glycosylation (HP:0012346) | 1.98548277 |
| 124 | Abnormal glycosylation (HP:0012345) | 1.98548277 |
| 125 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98548277 |
| 126 | Stomach cancer (HP:0012126) | 1.98453416 |
| 127 | Eosinophilia (HP:0001880) | 1.98399363 |
| 128 | Abnormality of the vitreous humor (HP:0004327) | 1.97666037 |
| 129 | Metaphyseal dysplasia (HP:0100255) | 1.97371361 |
| 130 | Abnormality of the umbilical cord (HP:0010881) | 1.96774762 |
| 131 | Axonal loss (HP:0003447) | 1.93721021 |
| 132 | Respiratory failure (HP:0002878) | 1.93563643 |
| 133 | Agnosia (HP:0010524) | 1.93557992 |
| 134 | Short tibia (HP:0005736) | 1.92205445 |
| 135 | Abolished electroretinogram (ERG) (HP:0000550) | 1.89716806 |
| 136 | Severe combined immunodeficiency (HP:0004430) | 1.87623878 |
| 137 | Petechiae (HP:0000967) | 1.86849576 |
| 138 | Type I transferrin isoform profile (HP:0003642) | 1.86737362 |
| 139 | Episodic fever (HP:0001954) | 1.86592822 |
| 140 | Posterior subcapsular cataract (HP:0007787) | 1.86475191 |
| 141 | Infantile muscular hypotonia (HP:0008947) | 1.86033993 |
| 142 | Abnormality of the labia minora (HP:0012880) | 1.84669788 |
| 143 | Abnormality of eosinophils (HP:0001879) | 1.84035575 |
| 144 | Septo-optic dysplasia (HP:0100842) | 1.83179252 |
| 145 | Abnormal neuron morphology (HP:0012757) | 1.81719784 |
| 146 | Abnormality of the motor neurons (HP:0002450) | 1.81719784 |
| 147 | Disinhibition (HP:0000734) | 1.81384916 |
| 148 | Emotional lability (HP:0000712) | 1.81331795 |
| 149 | Papillary thyroid carcinoma (HP:0002895) | 1.81163625 |
| 150 | Exertional dyspnea (HP:0002875) | 1.81099476 |
| 151 | Gangrene (HP:0100758) | 1.79735335 |
| 152 | Sensorimotor neuropathy (HP:0007141) | 1.79458436 |
| 153 | Abnormality of incisor morphology (HP:0011063) | 1.78476845 |
| 154 | Prominent occiput (HP:0000269) | 1.78180817 |
| 155 | Partial duplication of thumb phalanx (HP:0009944) | 1.77860206 |
| 156 | Septate vagina (HP:0001153) | 1.77804180 |
| 157 | Gonadotropin excess (HP:0000837) | 1.77608296 |
| 158 | Hypoglycemic seizures (HP:0002173) | 1.77127458 |
| 159 | Hypophosphatemic rickets (HP:0004912) | 1.76897444 |
| 160 | Vacuolated lymphocytes (HP:0001922) | 1.75263682 |
| 161 | Joint swelling (HP:0001386) | 1.75252929 |
| 162 | Acute hepatic failure (HP:0006554) | 1.74764804 |
| 163 | Optic disc pallor (HP:0000543) | 1.73712165 |
| 164 | Abnormal gallbladder physiology (HP:0012438) | 1.73164971 |
| 165 | Cholecystitis (HP:0001082) | 1.73164971 |
| 166 | Abnormality of T cells (HP:0002843) | 1.72493025 |
| 167 | Diastasis recti (HP:0001540) | 1.71390876 |
| 168 | Poor speech (HP:0002465) | 1.71109587 |
| 169 | Hypomagnesemia (HP:0002917) | 1.68169563 |
| 170 | Shoulder girdle muscle weakness (HP:0003547) | 1.67765279 |
| 171 | Partial agenesis of the corpus callosum (HP:0001338) | 1.67671262 |
| 172 | Leukocytosis (HP:0001974) | 1.66997704 |
| 173 | Choreoathetosis (HP:0001266) | 1.66985011 |
| 174 | Steatorrhea (HP:0002570) | 1.66683848 |
| 175 | Clitoromegaly (HP:0000057) | 1.65962977 |
| 176 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.64740345 |
| 177 | Absent epiphyses (HP:0010577) | 1.64740345 |
| 178 | Peripheral demyelination (HP:0011096) | 1.64210692 |
| 179 | Megalencephaly (HP:0001355) | 1.63805373 |
| 180 | Spastic tetraparesis (HP:0001285) | 1.61920525 |
| 181 | Progressive neurologic deterioration (HP:0002344) | 1.61523928 |
| 182 | Urinary incontinence (HP:0000020) | 1.61446575 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.23447926 |
| 2 | EPHB1 | 4.31842447 |
| 3 | OXSR1 | 4.08402901 |
| 4 | PBK | 4.08252786 |
| 5 | BCR | 3.36882267 |
| 6 | MAP4K2 | 3.02470625 |
| 7 | BCKDK | 2.65291347 |
| 8 | TESK2 | 2.59583274 |
| 9 | LIMK1 | 2.55645245 |
| 10 | MET | 2.49253773 |
| 11 | MAPKAPK5 | 2.44045274 |
| 12 | WNK4 | 2.21999781 |
| 13 | PKN1 | 2.03916889 |
| 14 | MST4 | 2.03517093 |
| 15 | NEK6 | 1.99419120 |
| 16 | CSNK1G3 | 1.98779248 |
| 17 | CDK19 | 1.94598462 |
| 18 | FES | 1.94135632 |
| 19 | CSNK1A1L | 1.90008094 |
| 20 | FGFR2 | 1.87924421 |
| 21 | CLK1 | 1.83094108 |
| 22 | TNIK | 1.77999070 |
| 23 | UHMK1 | 1.77290578 |
| 24 | TSSK6 | 1.75287694 |
| 25 | PRPF4B | 1.72765246 |
| 26 | PINK1 | 1.68002824 |
| 27 | TRIM28 | 1.62974993 |
| 28 | DYRK2 | 1.60694147 |
| 29 | WNK1 | 1.58381930 |
| 30 | SIK3 | 1.51023429 |
| 31 | SRPK1 | 1.46324220 |
| 32 | MKNK1 | 1.43075922 |
| 33 | CSNK1G1 | 1.42241436 |
| 34 | TEC | 1.41920382 |
| 35 | PLK2 | 1.40475161 |
| 36 | KDR | 1.39730401 |
| 37 | MAP3K12 | 1.30384352 |
| 38 | CCNB1 | 1.29219501 |
| 39 | BUB1 | 1.28386594 |
| 40 | NTRK2 | 1.27904506 |
| 41 | MAP3K4 | 1.26662663 |
| 42 | ROCK2 | 1.25857565 |
| 43 | TAOK3 | 1.25045810 |
| 44 | BMPR1B | 1.21741856 |
| 45 | STK16 | 1.17961118 |
| 46 | CSNK1G2 | 1.17280283 |
| 47 | KIT | 1.16821604 |
| 48 | MAP2K7 | 1.15542824 |
| 49 | CAMK2B | 1.10813395 |
| 50 | IRAK1 | 1.08271026 |
| 51 | IRAK2 | 1.05942641 |
| 52 | CAMKK2 | 1.03347364 |
| 53 | MAP3K5 | 0.99461864 |
| 54 | ADRBK2 | 0.98699214 |
| 55 | TIE1 | 0.98657338 |
| 56 | SGK223 | 0.94464720 |
| 57 | SGK494 | 0.94464720 |
| 58 | MINK1 | 0.93901045 |
| 59 | RPS6KA5 | 0.93734414 |
| 60 | CAMK2D | 0.90963304 |
| 61 | CSK | 0.90239425 |
| 62 | GRK7 | 0.90166876 |
| 63 | EPHA4 | 0.89911677 |
| 64 | NTRK1 | 0.88224739 |
| 65 | RPS6KA4 | 0.87197836 |
| 66 | IKBKE | 0.85486420 |
| 67 | SYK | 0.85053246 |
| 68 | PRKCQ | 0.82119632 |
| 69 | CDK14 | 0.82008192 |
| 70 | EPHA3 | 0.81819657 |
| 71 | GRK1 | 0.81529664 |
| 72 | INSRR | 0.79007276 |
| 73 | EIF2AK3 | 0.78228020 |
| 74 | FGR | 0.78018455 |
| 75 | LYN | 0.76438521 |
| 76 | PLK3 | 0.75280504 |
| 77 | ARAF | 0.74217499 |
| 78 | ICK | 0.70713720 |
| 79 | EIF2AK1 | 0.69930748 |
| 80 | MAP3K11 | 0.69528790 |
| 81 | DAPK1 | 0.68748258 |
| 82 | GRK6 | 0.68125319 |
| 83 | NEK1 | 0.65597955 |
| 84 | ERBB4 | 0.64176244 |
| 85 | CAMK2G | 0.63982338 |
| 86 | IRAK4 | 0.61837947 |
| 87 | CDK15 | 0.59657723 |
| 88 | MAPK13 | 0.59160982 |
| 89 | CDK18 | 0.59137172 |
| 90 | PIM2 | 0.58066143 |
| 91 | PNCK | 0.58040804 |
| 92 | KSR1 | 0.57538480 |
| 93 | GSK3A | 0.56913693 |
| 94 | RIPK4 | 0.56385117 |
| 95 | PAK3 | 0.56385037 |
| 96 | BMPR2 | 0.55745528 |
| 97 | MOS | 0.55504114 |
| 98 | PRKD1 | 0.53699785 |
| 99 | EGFR | 0.53062177 |
| 100 | PAK6 | 0.52019732 |
| 101 | TYRO3 | 0.51578208 |
| 102 | DYRK3 | 0.50927097 |
| 103 | CDK11A | 0.50527063 |
| 104 | RAF1 | 0.50133487 |
| 105 | FER | 0.49813762 |
| 106 | GRK5 | 0.48596723 |
| 107 | DAPK2 | 0.48357559 |
| 108 | PIM1 | 0.47999706 |
| 109 | PAK1 | 0.47842503 |
| 110 | MARK3 | 0.46951777 |
| 111 | ABL2 | 0.46902484 |
| 112 | PRKCG | 0.46195310 |
| 113 | CDK3 | 0.46060533 |
| 114 | JAK2 | 0.45680986 |
| 115 | TRPM7 | 0.45291810 |
| 116 | JAK3 | 0.44396143 |
| 117 | TAOK2 | 0.43241227 |
| 118 | STK38L | 0.42963311 |
| 119 | PRKCE | 0.42670778 |
| 120 | MATK | 0.42128163 |
| 121 | STK10 | 0.41330745 |
| 122 | ACVR1B | 0.37849341 |
| 123 | CSNK1D | 0.36542743 |
| 124 | YES1 | 0.36088590 |
| 125 | ITK | 0.35797410 |
| 126 | MAPK15 | 0.35483482 |
| 127 | CSNK1A1 | 0.34834930 |
| 128 | VRK1 | 0.32632328 |
| 129 | MUSK | 0.31943178 |
| 130 | CAMK2A | 0.31441932 |
| 131 | TESK1 | 0.29839277 |
| 132 | WNK3 | 0.29604658 |
| 133 | PRKD3 | 0.29559416 |
| 134 | FYN | 0.28922328 |
| 135 | STK4 | 0.28732372 |
| 136 | CDK5 | 0.28547281 |
| 137 | ERBB3 | 0.26355388 |
| 138 | IKBKB | 0.25888622 |
| 139 | BRAF | 0.25266227 |
| 140 | PIK3CA | 0.25214498 |
| 141 | LCK | 0.24504237 |
| 142 | NUAK1 | 0.24486160 |
| 143 | ABL1 | 0.24209396 |
| 144 | TBK1 | 0.22743021 |
| 145 | PRKACB | 0.21565639 |
| 146 | MELK | 0.21205559 |
| 147 | INSR | 0.21062129 |
| 148 | PDGFRB | 0.20699651 |
| 149 | MAP2K2 | 0.20571457 |
| 150 | MAPKAPK2 | 0.20055483 |
| 151 | PRKG1 | 0.20021677 |
| 152 | TXK | 0.18789439 |
| 153 | CSF1R | 0.18504398 |
| 154 | HIPK2 | 0.18118101 |
| 155 | DDR2 | 0.16984102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 6.76150551 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 5.83284904 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.65919327 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.13311409 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.10354270 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.05483933 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.03620168 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.88738924 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.11922563 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.01648827 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98334890 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.89335501 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87609412 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85182945 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73415257 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72165694 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.69119134 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.64746554 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.63369297 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52622484 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51008766 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.49107775 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38600413 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38427409 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34410910 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33911776 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33118708 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25441241 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23641269 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20256344 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19950553 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14750437 |
| 33 | Axon guidance_Homo sapiens_hsa04360 | 1.14252159 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03724853 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.02726566 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02301824 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01914200 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00898270 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98219690 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98185798 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98184520 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 0.98159213 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 0.98016576 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.97869958 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 0.95967247 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.95926380 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95657871 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94145650 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93417109 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91467406 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89559966 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.87944555 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.86873315 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 0.84690563 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82613853 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81439654 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81280591 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81006224 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80903560 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.80619390 |
| 61 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79659958 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78392163 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78289711 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78218288 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.76892832 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74251516 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71658544 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.70433785 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69683739 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69281292 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68061056 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67752700 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67117580 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65829132 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65452628 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.63857904 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62838325 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60019236 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.59583419 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55689313 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54171417 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54104975 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52397814 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51516316 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50642525 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49742347 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49214526 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.49036958 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48654845 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48374861 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48088167 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46769550 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46677019 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.46529989 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45411815 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.42936654 |
| 97 | Base excision repair_Homo sapiens_hsa03410 | 0.42651475 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42091580 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41265533 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40834515 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39091821 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38564360 |
| 103 | Mismatch repair_Homo sapiens_hsa03430 | 0.36728485 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.35915197 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35802815 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35599548 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34757787 |
| 108 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34727509 |
| 109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34257270 |
| 110 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33558949 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32660322 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31571376 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29853182 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29423318 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29201349 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29001168 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28743959 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.27763436 |
| 119 | Spliceosome_Homo sapiens_hsa03040 | 0.27707377 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26469974 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.26380171 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25729711 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.24789121 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22501991 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22074873 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21943757 |
| 127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21567155 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.20651595 |
| 129 | Long-term depression_Homo sapiens_hsa04730 | 0.20577458 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19986833 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19337358 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.18194968 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17894746 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17193610 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.14819048 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.14566450 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13090543 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.12105611 |
| 139 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.10674967 |
| 140 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.10344559 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.08838181 |
| 142 | DNA replication_Homo sapiens_hsa03030 | 0.08762451 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.07846321 |

